Inspire Investing’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$516K Buy
7,822
+492
+7% +$31.3K 0.03% 632
2025
Q4
$466K Sell
7,330
-862
-11% -$53.6K 0.04% 661
2025
Q3
$450K Sell
8,192
-3,696
-31% -$152K 0.04% 714
2025
Q2
$393K Buy
11,888
+3,337
+39% +$116K 0.04% 397
2025
Q1
$344K Buy
8,551
+47
+0.6% +$2.16K 0.04% 559
2024
Q4
$400K Buy
8,504
+616
+8% +$32K 0.04% 631
2024
Q3
$416K Buy
7,888
+1,317
+20% +$73.4K 0.04% 377
2024
Q2
$356K Buy
6,571
+1,484
+29% +$89.6K 0.04% 389
2024
Q1
$357K Buy
5,087
+605
+13% +$46.8K 0.04% 717
2023
Q4
$374K Sell
4,482
-5,882
-57% -$213K 0.04% 778
2023
Q3
$305K Buy
10,364
+753
+8% +$25.1K 0.04% 727
2023
Q2
$314K Buy
9,611
+1,927
+25% +$71.3K 0.04% 634
2023
Q1
$270K Buy
7,684
+2,521
+49% +$103K 0.03% 761
2022
Q4
$237K Buy
5,163
+828
+19% +$35.6K 0.03% 420
2022
Q3
$210K Sell
4,335
-1,027
-19% -$49.4K 0.03% 348
2022
Q2
$211K Sell
5,362
-26,297
-83% -$1.06M 0.03% 641
2022
Q1
$1.17M Buy
31,659
+26,192
+479% +$931K 0.13% 145
2021
Q4
$249K Sell
5,467
-1,595
-23% -$61.5K 0.03% 489
2021
Q3
$252K Buy
+7,062
New +$208K 0.03% 354

Other funds holding CYTK